Pathodiagnostic parameters for meningioma grading

Journal of Clinical Neuroscience

Volumn 15, Issue 12, 2008, Pages 1370-1375

  Moradi, A ^a   Semnani, V ^b   Djam, H ^a   Tajodini, A ^a   Zali, A R ^a   Ghaemi, K ^c   Nikzad, N ^a   Madani Civi, M ^d  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d National Iran Oil Company (NIOC)   (Iran)

Author keywords

Meningioma; Pathodiagnostic markers; Tumor grading

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN NECROSIS; CHILD; EPILEPSY; FEMALE; HEADACHE; HUMAN; HUMAN TISSUE; INTRACRANIAL TUMOR; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MITOSIS RATE; PRIORITY JOURNAL; VERTIGO; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; IRAN; MAGNETIC RESONANCE IMAGING; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; RETROSPECTIVE STUDIES; UBIQUITIN-PROTEIN LIGASES; X-RAY MICROTOMOGRAPHY; YOUNG ADULT;

EID: 55249112683     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2007.12.005     Document Type: Article

References (33)

1. Kepes J.J. Meningiomas. Biology, Pathology and Differential Diagnosis (1982), Masson, New York
2. Bondy M., and Ligon B.L. Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol 23 (1996) 197-205
3. Claus E.B., Bondy M.L., Schildkraut J.M., et al. Epidemiology of intracranial meningioma. Neurosurgery 57 (2005) 1088-1095
4. Thomsen J., Bisgaard M., and Tos M. Diagnostic and treatment problems in skull base meningiomas. Skull Base Surgery 1 (1999) 4-10
5. Chan R.C., and Thompson G.B. Morbidity, mortality, and quality of life following surgery for intracranial meningioma. A retrospective study of 257 cases. J Neurosurg 60 (1984) 52-60
6. In: Kleihnes P., and Cavenee W.K. (Eds). Pathology and Genetics. Tumors of the Nervous System: WHO Classification of Tumors (2000), IARC Press, Lyon 76-84
7. Ayerbe J., Lobato R.D., de la Cruz J., et al. Risk factors predicting recurrence in patients operated on for intracranial meningioma. A multivariate analysis. Acta Neurochir (Wien) 141 (1999) 921-932
8. Whittle I.R., Smith C., Navoo P., et al. Meningiomas. Lancet 363 (2004) 1535-1543
9. Kuratsu J., Kochi M., and Ushio Y. Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 92 (2000) 766-770
10. Nakamura M., Roser F., Michel J., et al. The natural history of incidental meningiomas. Neurosurgery 53 (2003) 62-71
11. Turgut M., Özcan O.E., Benli K., et al. Factors affecting morbidity and mortality following surgical intervention in patients with intracranial meningioma. ANZ Journal of Surgery 66 (1996) 144-150
12. Chen W.Y.K., and Liu H.C. Atypical (anaplastic) meningioma: relationship between histologic features and recurrence:a clinicopathologic study. Clin Neuropathol 9 (1990) 74-81
13. de la Monte S.M., Flickinger J., and Linggood R.M. Histopathologic features predicting recurrence of meningiomas following subtotal resection. Am J Surg Pathol 10 (1986) 836-843
14. Yao Y.-T. Clinicopathologic analysis of 615 cases of meningioma with special reference to recurrence. J Formos Med Assoc 93 (1994) 145-152
15. Jääskeläinen J., Haltia M., Laasonen E., et al. The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients. Surg Neurol 24 (1985) 165-172
16. Maier H., Öfner D., and Hittmair A. Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 77 (1992) 616-623
17. Perry A., Stafford S.L., Scheithauer B.W., et al. Meningioma grading. An analysis of histologic parameters. Am J Surg Pathol 21 (1997) 1455-1465
18. Kern S.B. Prevalence of psammoma bodies in Papanicolaou-stained cervicovaginal smears. Acta Cytol 35 (1990) 81-88
19. Arnaudova V., and Romansky K. Postoperative hematomas following 505 operations for intracranial meningiomas. Zent bl Neurochir 50 (1989) 99-100
20. Perry A., Scheithauer B.W., Stafford S.L., et al. "Malignancy" in meningiomas. A clinicopathologic study of 116 patients, with grading implications. Cancer 85 (1999) 2046-2056
21. Donhuijsen K., Sastry M., Volker B., et al. Mast cell frequency in soft tissue tumors. Relation to type and grade of malignancy. Pathol Res Pract 188 (1992) 61-66
22. Katenkamp D., and Hunerbein R. The prognostic significance of inflammatory cells in malignant human soft tissue tumors: malignancy grading. Zentralbl Pathol 138 (1992) 21-25
23. Burger P.C., Scheithauer B.W., and Vogel F.S. Surgical Pathology of the Nervous System and its Coverings. 3rd ed. (1991), Churchill Livingstone, New York p. 67-91
24. Devprasath A., and Chocko G. Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas. Neurology India 51 (2003) 336-340
25. Ohta M., Iwaki T., Kitamoto T., et al. MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management. Cancer 74 (1994) 3176-3189
26. Aguiar P.H., Tsanaclis A.M., Tella O.I., et al. Proliferation rate of intracranial meningiomas as defined by the monoclonal antibody MIB-1. Neurosurg Rev 26 (2003) 221-228
27. Guillou L., Coindre J.M., Bonichon F., et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 15 (1997) 350-362
28. Hasegawa T., Yokoyama R., Lee Y.H., et al. Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma. Oncology 58 (2000) 66-74
29. Matsuno A., Fujimaki T., Sasaki T., et al. Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol 91 (1996) 504-510
30. Abramovich C.M., and Prayson R.A. Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas. Arch Pathol Lab Med 123 (1999) 793-800
31. Prayson R.A. Malignant meningioma: a clinicopathologic study of 23 patients including MIB1 and p53 immunohistochemistry. Am J Clin Pathol 105 (1996) 719-726
32. Nakasu S., Li D.H., Okabe H., et al. Significance of MIB-1 staining indices in meningiomas. Comparison of two counting methods. Am J Surg Pathol 25 (2001) 472-478
33. Møller M., and Brændstrup O. No prediction of recurrence of meningiomas by PCNA and Ki-67 immunohistochemistry. J Neurooncol 34 (1997) 241-246